News

The biologics pilot plant will allow UCB to further optimize the bio-manufacturing processes for its biological compounds under development, extending its knowledge and competencies in this field. This

Previously, Mr Williams was a founding member of the Partnership for Prevention, an organization of public and private sector representatives who focus on preventive healthcare policies. Mr Williams

Dr Henderson joins the Cytokinetics board of directors with over 30 years of experience in the life science industry. Since December 2000, Dr Henderson has served as a

The Phase I trial has been designed to compare pharmacokinetics in Parkinson’s patients of two formulations of DM-1992 and a generic version of Sinemet CR, a commercially available

Following the promising results generated in the frame of the initial collaboration established between Flamel and Merck Serono in 2007, Merck Serono has made the decision to exercise

These offices comprise more than 80% of Gentiva’s current pediatric care operations. Terms have not been disclosed. According to Gentiva, the transaction fits with its stated objective of

The net profit for 2008 was E367.1 million, or E1.69 per share, compared with E3.5 billion, or E16.21 per share, for the full year 2007. Revenue for the

The Phase III program will include more than 4,000 patients. The Phase III program for albiglutide will begin with five studies in early 2009. The objective of the

In the transaction, GPC Biotech is to be merged onto a new German company, which will hold all of the shares of Agennix and a E15 million cash